1. Home
  2. DXCM vs ARE Comparison

DXCM vs ARE Comparison

Compare DXCM & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • ARE
  • Stock Information
  • Founded
  • DXCM 1999
  • ARE 1994
  • Country
  • DXCM United States
  • ARE United States
  • Employees
  • DXCM N/A
  • ARE N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • ARE Real Estate Investment Trusts
  • Sector
  • DXCM Health Care
  • ARE Real Estate
  • Exchange
  • DXCM Nasdaq
  • ARE Nasdaq
  • Market Cap
  • DXCM 34.1B
  • ARE 12.6B
  • IPO Year
  • DXCM 2005
  • ARE 1997
  • Fundamental
  • Price
  • DXCM $83.58
  • ARE $77.15
  • Analyst Decision
  • DXCM Strong Buy
  • ARE Hold
  • Analyst Count
  • DXCM 20
  • ARE 9
  • Target Price
  • DXCM $98.50
  • ARE $117.11
  • AVG Volume (30 Days)
  • DXCM 3.7M
  • ARE 1.7M
  • Earning Date
  • DXCM 07-30-2025
  • ARE 07-21-2025
  • Dividend Yield
  • DXCM N/A
  • ARE 6.86%
  • EPS Growth
  • DXCM N/A
  • ARE N/A
  • EPS
  • DXCM 1.33
  • ARE 0.76
  • Revenue
  • DXCM $4,148,000,000.00
  • ARE $3,111,841,000.00
  • Revenue This Year
  • DXCM $16.74
  • ARE N/A
  • Revenue Next Year
  • DXCM $15.29
  • ARE $2.72
  • P/E Ratio
  • DXCM $62.88
  • ARE $100.96
  • Revenue Growth
  • DXCM 9.11
  • ARE 5.31
  • 52 Week Low
  • DXCM $57.52
  • ARE $67.37
  • 52 Week High
  • DXCM $117.19
  • ARE $130.14
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 49.67
  • ARE 62.09
  • Support Level
  • DXCM $82.50
  • ARE $74.53
  • Resistance Level
  • DXCM $84.46
  • ARE $77.19
  • Average True Range (ATR)
  • DXCM 2.60
  • ARE 1.93
  • MACD
  • DXCM -0.21
  • ARE 0.55
  • Stochastic Oscillator
  • DXCM 53.66
  • ARE 92.85

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Share on Social Networks: